600351.SS

Yabao Pharmaceutical Group Co., Ltd [600351.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

600351.SS Stock Summary

Top 10 Correlated Stocks

600351.SS


In the News

600351.SS Financial details

Company Rating
Buy
Market Cap
4.76B
Income
211.08M
Revenue
2.94B
Book val./share
4.02
Cash/share
0.78
Dividend
0.05
Dividend %
0.75%
Employees
4.37K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
23.97
Forward P/E
-
PEG
16.21
P/S
1.8
P/B
1.66
P/C
7.77
P/FCF
21.57
Quick Ratio
1.67
Current Ratio
2.18
Debt / Equity
0.08
LT Debt / Equity
0
-
-
EPS (TTM)
0.28
EPS next Y
-
EPS next Q
-
EPS this Y
-41.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-16.74%
Revenue last 5Y
-1.41%
Revenue Q/Q
-8.98%
EPS Q/Q
-23.13%
-
-
-
-
SMA20
-
SMA50
-14.29%
SMA100
-25%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
7%
ROC
0.08%
Gross Margin
56%
Oper. Margin
8%
Profit Margin
7%
Payout
26%
Shs Outstand
760M
Shs Float
574.29M
-
-
-
-
Target Price
-
52W Range
4.94-9.0
52W High
-32.67%
52W Low
+51.5%
RSI
43
Rel Volume
1.21
Avg Volume
22.09M
Volume
26.64M
Perf Week
-3.96%
Perf Month
-0.98%
Perf Quarter
-
Perf Half Y
-28.62%
-
-
-
-
Beta
0.277
-
-
Volatility
0.12%, 0.1%
Prev Close
0.66%
Price
6.06
Change
-1.3%

600351.SS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
3.724.373.393.593.64
Net income per share
0.350.020.140.240.14
Operating cash flow per share
0.540.610.50.570.62
Free cash flow per share
0.460.390.410.440.53
Cash per share
1.030.620.460.560.84
Book value per share
3.693.873.623.83.97
Tangible book value per share
3.133.443.213.363.54
Share holders equity per share
3.693.873.623.83.97
Interest debt per share
1.371.390.890.730.62
Market cap
4.36B4.05B3.82B6.99B4.4B
Enterprise value
4.61B4.49B4.12B7.05B4.17B
P/E ratio
15.96375.4135.5737.3742
Price to sales ratio
1.51.331.472.531.62
POCF ratio
10.239.5310.0315.989.55
PFCF ratio
12.1715.1212.0120.4211.04
P/B Ratio
1.511.511.372.391.48
PTB ratio
1.511.511.372.391.48
EV to sales
1.581.481.582.551.53
Enterprise value over EBITDA
8.378.1412.1916.9510.85
EV to operating cash flow
10.8210.5610.8116.129.05
EV to free cash flow
12.8716.7412.9420.610.47
Earnings yield
0.0600.030.030.02
Free cash flow yield
0.080.070.080.050.09
Debt to equity
0.360.340.230.180.15
Debt to assets
0.220.210.160.130.11
Net debt to EBITDA
0.460.790.880.15-0.59
Current ratio
1.391.41.571.791.88
Interest coverage
9.57.883.918.9911.74
Income quality
1.539.373.52.384.4
Dividend Yield
0.030.060.010.010.02
Payout ratio
0.4122.30.460.320.78
Sales general and administrative to revenue
0.020.020.020.020.02
Research and developement to revenue
0.040.040.060.060.05
Intangibles to total assets
0.110.080.090.090.09
Capex to operating cash flow
-0.16-0.37-0.17-0.22-0.14
Capex to revenue
-0.02-0.05-0.02-0.03-0.02
Capex to depreciation
-0.4-0.91-0.37-0.56-0.38
Stock based compensation to revenue
00000
Graham number
5.381.163.384.563.54
ROIC
0.070.020.030.050.05
Return on tangible assets
0.0600.030.050.03
Graham Net
0-0.170.060.210.46
Working capital
655.57M594.92M625.03M791.68M913.67M
Tangible asset value
2.46B2.39B2.46B2.59B2.65B
Net current asset value
533.82M481.69M529.1M683.99M829.91M
Invested capital
0.360.340.230.180.15
Average receivables
921.27M990.93M931.48M819.01M804.22M
Average payables
235.55M218.55M157.18M152.25M174.52M
Average inventory
532.74M559.25M529.84M509.51M485.07M
Days sales outstanding
121.91120.86120.02103.31110.94
Days payables outstanding
86.4353.1452.7651.3260.13
Days of inventory on hand
174.52185.01171.69176.55136.68
Receivables turnover
2.993.023.043.533.29
Payables turnover
4.226.876.927.116.07
Inventory turnover
2.091.972.132.072.67
ROE
0.0900.040.060.04
Capex per share
-0.09-0.23-0.08-0.12-0.08

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.8811.040.960.88
Net income per share
0.0100.140.080.06
Operating cash flow per share
0.0100.140.210.11
Free cash flow per share
-0.01-0.030.110.170.06
Cash per share
0.760.8410.870.78
Book value per share
3.863.9743.994.02
Tangible book value per share
3.43.543.583.553.56
Share holders equity per share
3.863.9743.994.02
Interest debt per share
0.710.60.590.470.33
Market cap
4.39B4.4B5.44B5.4B6.41B
Enterprise value
4.35B4.17B5.12B5.09B6.08B
P/E ratio
121.73-400.9912.6522.2635.02
Price to sales ratio
6.465.96.797.379.62
POCF ratio
486.93-1.6K50.6133.6680.38
PFCF ratio
-780.04-200.6663.1440.78130.77
P/B Ratio
1.481.481.771.782.11
PTB ratio
1.481.481.771.782.11
EV to sales
6.45.596.46.959.12
Enterprise value over EBITDA
1.2K52.3838.0172.78123.71
EV to operating cash flow
482.37-1.52K47.7131.7376.19
EV to free cash flow
-772.74-190.359.5238.44123.96
Earnings yield
000.020.010.01
Free cash flow yield
000.020.020.01
Debt to equity
0.180.150.150.120.08
Debt to assets
0.130.110.110.090.06
Net debt to EBITDA
-11.35-2.85-2.31-4.42-6.8
Current ratio
1.861.882.032.132.18
Interest coverage
0.31-1.0431.7814.3722.63
Income quality
1112.651.74
Dividend Yield
0000.010
Payout ratio
0.49-2.330.040.710.06
Sales general and administrative to revenue
0.25-0.190.08-0.060.27
Research and developement to revenue
0.060.050.030.030.05
Intangibles to total assets
0.10.090.090.090.1
Capex to operating cash flow
-1.626.99-0.2-0.17-0.39
Capex to revenue
-0.02-0.03-0.03-0.04-0.05
Capex to depreciation
-0.36-0.47-0.53-0.70.39
Stock based compensation to revenue
00000
Graham number
1.010.573.542.672.34
ROIC
000.030.020.01
Return on tangible assets
000.030.020.01
Graham Net
0.450.460.690.670.63
Working capital
863.31M913.67M1.04B992.39M961.5M
Tangible asset value
2.62B2.65B2.75B2.69B2.7B
Net current asset value
782.82M829.91M963.7M911.19M885.14M
Invested capital
0.180.150.150.120.08
Average receivables
816.56M822.03M848.43M838.54M788.92M
Average payables
165.05M179.24M199.65M197.8M196.74M
Average inventory
460.62M446.62M433.94M405.71M399.37M
Days sales outstanding
108.4599.7497.8999.1104.16
Days payables outstanding
47.8853.3154.8953.7461.22
Days of inventory on hand
132.16121.19113.94108.86124.55
Receivables turnover
0.830.90.920.910.86
Payables turnover
1.881.691.641.671.47
Inventory turnover
0.680.740.790.830.72
ROE
000.030.020.02
Capex per share
-0.02-0.03-0.03-0.04-0.04

600351.SS Frequently Asked Questions

What is Yabao Pharmaceutical Group Co., Ltd stock symbol ?

Yabao Pharmaceutical Group Co., Ltd is a CN stock and trading under the symbol 600351.SS

What is Yabao Pharmaceutical Group Co., Ltd stock quote today ?

Yabao Pharmaceutical Group Co., Ltd stock price is $6.06 today.

Is Yabao Pharmaceutical Group Co., Ltd stock public?

Yes, Yabao Pharmaceutical Group Co., Ltd is a publicly traded company.

Something similar